The Relevance of New Drug Combinations for Modern Tuberculosis Treatment - A Patent Perspective

ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)

Volume 12, 2 Issues, 2017

Download PDF Flyer

Recent Patents on Anti-Infective Drug Discovery

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Dieter Kabelitz
Institute of Immunology
Universitätsklinikum Schleswig-Holstein
Campus Kiel
Arnold-Heller-Straße 3
Kiel, D-24105

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

The Relevance of New Drug Combinations for Modern Tuberculosis Treatment - A Patent Perspective

Recent Patents on Anti-Infective Drug Discovery, 8(2): 130-138.

Author(s): Alessandra C. Pinheiro and Marcus V N de Souza.

Affiliation: FioCruz - Fundacao Oswaldo Cruz, Instituto de Tecnologia em Farmacos – Far Manguinhos, Rua Sizenando Nabuco, 100, Manguinhos, 21041-250 Rio de Janeiro, RJ, Brazil.


Drug combinations (DCs) have been successfully used in different kinds of diseases such as cancer, AIDS, malaria, infectious diseases, asthma, diarrhea, hypertension, neurological disorders, among others. In this context, an important concept in drug discovery relates to the fixed-dose combinations (FDC), which can be defined as a formulation of two or more biologically active substances, combined in a single drug, and available at certain fixed doses. FDC presents several advantages, such as reduced risks of emergence of drug resistant strains, improvement of patient compliance, reduced costs of treatment and a simplified drug supply management, shipping and distribution. Due to the importance of DCs in drug discovery, the purpose of this review is to highlight the importance of this strategy for tuberculosis treatment and also for studies of new promising drug combinations to be used against this disease, specially focused on resistant bacterial strains. Relevant patents concerning combined treatment of tuberculosis are analyzed.


Drug combinations, Tuberculosis, fixed-dose combinations, MDR-TB, XDR-TB.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 8
Issue Number: 2
First Page: 130
Last Page: 138
Page Count: 9
DOI: 10.2174/1574891X113089990001
Price: $100

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science